Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma is a research paper published in Molecular Oncology (2021). On theSindex it has a DataRank of 0.959. It has been cited 22 times, with 18 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.470
From this paper's citation signal
Citation Network Contribution
0.489
From 16 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 18 citers.
National Science Foundation
Grant: GRFP DGE‐0718123
Prostate Cancer Foundation
Grant: Young Investigator Award
National Institutes of Health
Grant: 1R01CA181648
National Institutes of Health
Grant: 5R33CA137673
National Institutes of Health
Grant: P30 CA014520
NCI NIH HHS
Grant: R01 CA181648
NCI NIH HHS
Grant: R33 CA137673
NIH HHS
Grant: S10 OD018202
National Institutes of Health
Grant: 1R33CA137673-01
Microchannel cell-based assays to enable cancer research
National Science Foundation
Grant: 0718123
GRADUATE RESEARCH FELLOWSHIP PROGRAM
National Institutes of Health
Grant: 5R01CA181648-02
VERSA: An Integrated, Multi-Endpoint Platform for Circulating Tumor Cell Analysis
National Institutes of Health
Grant: 5P30CA014520-18
CANCER CENTER SUPPORT
FWCI
1.62
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals